Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 CAD | -2.43% | +4.03% | +48.56% |
May. 15 | Transcript : Ayr Wellness Inc., Q1 2024 Earnings Call, May 15, 2024 | |
May. 15 | Ayr Wellness Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 249.8 | 885.8 | 1,019 | 86.74 | 141.7 | 299.2 | - | - |
Enterprise Value (EV) 2 | 299.5 | 949.2 | 1,247 | 663.9 | 726.9 | 706.1 | 747.7 | 299.2 |
P/E ratio | -0.98 x | -3.78 x | -50.1 x | -0.33 x | -0.49 x | -1.7 x | -7.07 x | -16 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 3.32 x | 5.71 x | 2.85 x | 0.19 x | 0.31 x | 0.61 x | 0.54 x | 0.53 x |
EV / Revenue | 3.98 x | 6.12 x | 3.49 x | 1.43 x | 1.57 x | 1.44 x | 1.35 x | 0.53 x |
EV / EBITDA | 14.3 x | 16.9 x | 12.7 x | 7.65 x | 6.38 x | 5.76 x | 5.17 x | 2.18 x |
EV / FCF | -27.6 x | 42.9 x | -9.76 x | -6.87 x | -69.1 x | 118 x | -22 x | - |
FCF Yield | -3.62% | 2.33% | -10.2% | -14.6% | -1.45% | 0.85% | -4.55% | - |
Price to Book | - | 4.44 x | 0.85 x | - | 0.23 x | 0.77 x | - | - |
Nbr of stocks (in thousands) | 26,502 | 37,297 | 67,326 | 71,718 | 77,286 | 110,027 | - | - |
Reference price 3 | 12.25 | 30.25 | 19.14 | 1.640 | 2.430 | 3.700 | 3.700 | 3.700 |
Announcement Date | 2/26/20 | 3/10/21 | 3/17/22 | 3/9/23 | 3/13/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 75.2 | 155.1 | 357.6 | 465.6 | 463.6 | 489.6 | 553.8 | 561.2 |
EBITDA 1 | 20.9 | 56.19 | 97.97 | 86.82 | 114 | 122.6 | 144.5 | 137.4 |
EBIT 1 | -23.46 | 16.12 | -56.01 | -243 | -37.21 | 16.8 | 22.25 | 59.6 |
Operating Margin | -31.19% | 10.39% | -15.66% | -52.19% | -8.03% | 3.43% | 4.02% | 10.62% |
Earnings before Tax (EBT) 1 | -159.3 | -152 | 12.31 | -210.1 | -45.76 | -51.24 | 11.7 | 30.7 |
Net income 1 | -164.2 | -176.3 | -16.95 | -245.5 | -272.4 | -146.5 | -52.7 | 22.2 |
Net margin | -218.34% | -113.68% | -4.74% | -52.72% | -58.76% | -29.93% | -9.52% | 3.96% |
EPS 2 | -12.54 | -7.994 | -0.3822 | -4.935 | -4.969 | -2.176 | -0.5235 | -0.2315 |
Free Cash Flow 1 | -10.84 | 22.14 | -127.8 | -96.66 | -10.51 | 6 | -34 | - |
FCF margin | -14.42% | 14.28% | -35.73% | -20.76% | -2.27% | 1.23% | -6.14% | - |
FCF Conversion (EBITDA) | - | 39.41% | - | - | - | 4.89% | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/26/20 | 3/10/21 | 3/17/22 | 3/9/23 | 3/13/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 111.8 | 111.2 | 110.1 | 119.6 | 124.6 | 117.7 | 116.7 | 114.4 | 114.8 | 118 | 119.7 | 124.2 | 128.3 | 132.9 | 134 |
EBITDA 1 | 26.14 | 19.5 | 19.64 | 21.67 | 26.01 | 26.34 | 29.45 | 28.43 | 29.76 | 29.09 | 29.57 | 31.19 | 32.21 | 35.7 | 36 |
EBIT 1 | -13.86 | -21.13 | -24.8 | -20.68 | -176.2 | -21.68 | -4.539 | -1.451 | -9.544 | -1.963 | 3.5 | 4.5 | 5.4 | - | - |
Operating Margin | -12.4% | -18.99% | -22.52% | -17.29% | -141.41% | -18.43% | -3.89% | -1.27% | -8.31% | -1.66% | 2.92% | 3.62% | 4.21% | - | - |
Earnings before Tax (EBT) 1 | 33.41 | 2.114 | -30.56 | -26.84 | -154.8 | -1.205 | -18.32 | -5.727 | -20.51 | -96.85 | -7.033 | -5.667 | -5.1 | - | - |
Net income 1 | 23.79 | -7.576 | -38.36 | -36.12 | -166.4 | -194.6 | -29.93 | -19.25 | -28.28 | -106.1 | -30.9 | -31.1 | -31.1 | - | - |
Net margin | 21.28% | -6.81% | -34.83% | -30.19% | -133.53% | -165.39% | -25.64% | -16.82% | -24.62% | -89.86% | -25.81% | -25.05% | -24.24% | - | - |
EPS 2 | 0.4460 | -0.1412 | -0.7235 | -0.6997 | -3.309 | -3.752 | -0.5540 | -0.3415 | -0.4996 | -1.469 | -0.3670 | -0.3540 | -0.3540 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/17/22 | 5/26/22 | 8/18/22 | 11/10/22 | 3/9/23 | 5/16/23 | 8/17/23 | 11/16/23 | 3/13/24 | 5/15/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 49.7 | 63.4 | 228 | 577 | 585 | 407 | 448 | - |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.379 x | 1.128 x | 2.328 x | 6.648 x | 5.135 x | 3.318 x | 3.103 x | - |
Free Cash Flow 1 | -10.8 | 22.1 | -128 | -96.7 | -10.5 | 6 | -34 | - |
ROE (net income / shareholders' equity) | - | -110% | -2.6% | - | -38.8% | -15.6% | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | -16.9% | -8.8% | - | - |
Assets 1 | - | - | - | - | 1,614 | 1,665 | - | - |
Book Value Per Share 2 | - | 6.820 | 22.50 | - | 10.40 | 4.820 | - | - |
Cash Flow per Share 2 | 0.3000 | 1.650 | -0.6100 | -0.6700 | 0.4900 | -0.4000 | - | - |
Capex 1 | 14.4 | 14.4 | 100 | 62.5 | 27.7 | 31 | 24 | - |
Capex / Sales | 19.17% | 9.26% | 27.96% | 13.42% | 5.97% | 6.33% | 4.33% | - |
Announcement Date | 2/26/20 | 3/10/21 | 3/17/22 | 3/9/23 | 3/13/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.15% | 299M | |
-.--% | 339M | |
+25.77% | 279M | |
+52.91% | 206M | |
+161.28% | 154M | |
+43.48% | 132M | |
-28.57% | 122M | |
-43.53% | 119M | |
+11.54% | 118M | |
+50.00% | 60.26M |
- Stock Market
- Equities
- AYR.A Stock
- Financials Ayr Wellness Inc.